NuVasive's EBIT per Share for the
three
months ended in Jun. 2023 was $0.35.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.97.
During the past 12 months, the average EBIT per Share Growth Rate of NuVasive was 29.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -13.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -11.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 6.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for NuVasive's EBIT per Share or its related term are showing as below:
NUVA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -22.5 Med: 25 Max: 60.7
Current: -13.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of NuVasive was 60.70% per year. The lowest was -22.50% per year. And the median was 25.00% per year.
NUVA's 3-Year EBIT Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 6.75
vs NUVA: -13.10
NuVasive's EBIT for the
three
months ended in Jun. 2023 was $18 Mil.
NuVasive EBIT per Share Historical Data
The historical data trend for NuVasive's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NuVasive (NAS:NUVA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
NuVasive EBIT per Share Related Terms
Thank you for viewing the detailed overview of NuVasive's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUVA has been successfully added to your 